Supply of Clindamycin Hydrochloride Capsules (300 mg) – FDA-Compliant Pharmaceutical Manufacturing

The contract entails the manufacture and supply of 2,000 bottles of Clindamycin Hydrochloride Capsules at a strength of 300 mg, fully compliant with FDA regulations, current Good Manufacturing Practices, and Department of Defense standards. All production must originate from approved manufacturers possessing designated CAGE and NDC codes to ensure traceability and regulatory adherence. The procurement is structured as a subcontract under the Defense Logistics Agency, part of the Department of Defense, and falls under the NAICS code 325412 for pharmaceutical preparation manufacturing. The solicitation was posted on August 9, 2026, with performance occurring at an unspecified location tied to the DLA logistics network. The contract is identified by the award number SPE2DX25D8022 and delivery order SPE2D926F8122, linking it directly to the DIBBS system for accountability and procurement tracking.